SMA May Be Linked to Cognitive Impairment in Chinese Patients
A cross-sectional study suggests that spinal muscular atrophy (SMA) can contribute to cognitive impairment.
Source: ajmc.com
Revised Upper Limb Module News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Revised Upper Limb Module. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Revised Upper Limb Module Today - Breaking & Trending Today
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript
Rushmie Nofsinger: Good morning. I'm Rushmie Nofsinger, Vice President of Corporate Affairs and Investor Relations at Scholar Rock.
Source: insidermonkey.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2023 Earnings Call Transcript November 7, 2023 Rushmie Nofsinger: Good morning. I’m Rushmie Nofsinger, Vice President of Corporate Affairs and Investor Relations at Scholar Rock. Welcome, and thank you for joining us today for our Q3 2023 Business Update Call. This call is audio-only. You can access the slides […]
Source: yahoo.com
Risdiplam May Be Safe and Effective in SMA Care
Risdiplam appears to be an effective therapeutic option for patients with spinal muscular atrophy, leading to improved motor function, a study found.
Source: neurologyadvisor.com
NHI to cover NT$49 million gene therapy drug for muscle atrophy
Taipei, June 24 (CNA) A one-time-only drug to treat spinal muscular atrophy (SMA) that will cost NT$49 million (US$1.58 million) will soon be covered for infants six months old and under by Taiwan's universal health insurance system.
Source: focustaiwan.tw